Groupe Francophone Des Myelodysplasies

Research activity centers on myelodysplastic syndromes across low-risk, intermediate-risk, higher-risk, and very high-risk disease, including patients with transfusion-dependent anemia and those who are ineligible for allogeneic transplantation.

• Lower-risk MDS with anemia
• Higher-risk MDS and transplant-ineligible disease
• Myelodysplastic syndromes with transfusion dependence
• Post-transplant relapse in myeloid disease

Trials also address erythroid failure, hematologic improvement, and disease control in patients who have not responded to standard supportive or disease-directed treatment.